Artur C. Fassoni, Christoph Baldow, Ingo Roeder, and Ingmar Glauche. 2018. “Reduced Tyrosine Kinase Inhibitor Dose Is Predicted to Be As Effective As Standard Dose in Chronic Myeloid Leukemia: A Simulation Study Based on Phase III Trial Data”. Haematologica 103 (11). Pavia, Italy, 1825-34. https://doi.org/10.3324/haematol.2018.194522.